Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Fass

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
Factor VIII structure and functionD N Fass
Archives of Biochemistry and Biophysics|September 1, 1984
Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketoneP Lollar, D N Fass
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1983
Porcine cardiac valvular endothelial cells in culture. A relative deficiency of fibronectin synthesis in vitroC M Johnson, D N Fass
Mayo Clinic Proceedings|December 1, 1974
Calcium and prothrombin activationK G Mann, D N Fass
Lancet (London, England)|March 29, 1980
Factor VIII antigen pre-peakE J Bowie, D N Fass
The Journal of Biological Chemistry|May 10, 1973
Activation of fluorescein-labeled prothrombinD N Fass, K G Mann
Clinics in Haematology|June 1, 1985
Genetic engineering and coagulation factorsD N Fass, J J Toole
Thrombosis Research|January 1, 1979
Electrophoretic mobility of platelets from normal and bleeder swineB S Coller, D N Fass
Blood|March 1, 1982
Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysisG J Knutson, D N Fass
Lancet (London, England)|November 17, 1979
Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriersE J Bowie, D N Fass
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Annals of the New York Academy of Sciences|January 1, 1991
Factor VIII structure and functionD N Fass
Archives of Biochemistry and Biophysics|September 1, 1984
Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketoneP Lollar, D N Fass
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1983
Porcine cardiac valvular endothelial cells in culture. A relative deficiency of fibronectin synthesis in vitroC M Johnson, D N Fass
Mayo Clinic Proceedings|December 1, 1974
Calcium and prothrombin activationK G Mann, D N Fass
Lancet (London, England)|March 29, 1980
Factor VIII antigen pre-peakE J Bowie, D N Fass
The Journal of Biological Chemistry|May 10, 1973
Activation of fluorescein-labeled prothrombinD N Fass, K G Mann
Clinics in Haematology|June 1, 1985
Genetic engineering and coagulation factorsD N Fass, J J Toole
Thrombosis Research|January 1, 1979
Electrophoretic mobility of platelets from normal and bleeder swineB S Coller, D N Fass
Blood|March 1, 1982
Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysisG J Knutson, D N Fass
Lancet (London, England)|November 17, 1979
Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriersE J Bowie, D N Fass
Pageof 8